Budúce P/E spoločnosti Agios Pharmaceuticals Inc
Aká je hodnota metriky Budúce P/E spoločnosti Agios Pharmaceuticals Inc?
Hodnota metriky Budúce P/E spoločnosti Agios Pharmaceuticals Inc je -3.82
Aká je definícia metriky Budúce P/E?
Budúci pomer P/E (Forward price to earnings ratio) vyjadruje pomer súčasnej ceny a odhadovaného zisku na akciu za ďalších 12 mesiacov.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Budúce P/E spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Agios Pharmaceuticals Inc
Čomu sa venuje spoločnosť Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Firmy s metrikou budúce p/e podobnou spoločnosti Agios Pharmaceuticals Inc
- Hodnota metriky Budúce P/E spoločnosti Peloton Interactive Inc je -3.88
- Hodnota metriky Budúce P/E spoločnosti aap Implantate AG je -3.84
- Hodnota metriky Budúce P/E spoločnosti Pharnext SA je -3.84
- Hodnota metriky Budúce P/E spoločnosti Tinka Resources je -3.83
- Hodnota metriky Budúce P/E spoločnosti Trilogy International Partners je -3.82
- Hodnota metriky Budúce P/E spoločnosti Midas Gold je -3.82
- Hodnota metriky Budúce P/E spoločnosti Agios Pharmaceuticals Inc je -3.82
- Hodnota metriky Budúce P/E spoločnosti Recon Technology Ltd je -3.80
- Hodnota metriky Budúce P/E spoločnosti Ballard Power Systems je -3.79
- Hodnota metriky Budúce P/E spoločnosti comScore je -3.78
- Hodnota metriky Budúce P/E spoločnosti Avenue Therapeutics Inc je -3.74
- Hodnota metriky Budúce P/E spoločnosti Compugen Ltd je -3.73
- Hodnota metriky Budúce P/E spoločnosti Vir Biotechnology Inc je -3.70